[−2]proPSA versus ultrasensitive PSA fluctuations over time in the first year from radical prostatectomy, in an high-risk prostate cancer population: A first report

BACKGROUND: [−2]proPSA and its derivatives have an higher diagnostic accuracy than PSA in predicting prostate cancer (PCa). In alternative to PSA, ultrasensitive PSA (uPSA) and [−2]proPSA could be potentially useful in recurrent disease detection. This research focused on [−2]proPSA and uPSA fluctua...

Descripción completa

Detalles Bibliográficos
Autores principales: De Luca, S., Passera, R., Sottile, A., Fiori, C., Scarpa, R. M., Porpiglia, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806444/
https://www.ncbi.nlm.nih.gov/pubmed/27013515
http://dx.doi.org/10.1186/s12894-016-0131-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806444/
https://www.ncbi.nlm.nih.gov/pubmed/27013515
http://dx.doi.org/10.1186/s12894-016-0131-0

Ejemplares similares